| Symbol | COR |
|---|---|
| Name | CENCORA, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Other Pharmaceuticals |
| Address | 1 WEST FIRST AVENUE, CONSHOHOCKEN, Pennsylvania, 19428-1800, United States |
| Telephone | +1 610 - 727-7000 |
| Fax | — |
| — | |
| Website | https://www.cencora.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001140859 |
| Description | Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers compensation and specialty drug patients. Additional info from NASDAQ: |
Director Tyler Lauren M 🟢 acquired 99 shares of Cencora, Inc. (COR) at $304.00 Transaction Date: May 01, 2026 | Filing ID: 000004
Read moreDirector NALLY DENNIS M 🟢 acquired 116 shares of Cencora, Inc. (COR) at $304.00 Transaction Date: May 01, 2026 | Filing ID: 000004
Read moreNew Form SCHEDULE 13G - Cencora, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0002100119-26-000328 <b>Size:</b> 7 KB
Read moreKrikorian Lazarus 🟢 acquired 3.9K shares (1 derivative) of Cencora, Inc. (COR) Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read moreCencora - Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
Read moreCencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
Read moreNew Form SCHEDULE 13G/A - Cencora, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000928 <b>Size:</b> 7 KB
Read moreCencora - Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
Read moreCencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
Read more